ArticleResearch square2026

YBX1 Promotes Drug Resistance in Hepatocellular Carcinoma and Serves as a Potential Therapeutic Target.

Manish Tripathi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.